TYME Technologies appoints Richie Cunningham as CEO alongside Steve Hoffman remaining Board Chairman and CSO

– USA, NJ –  Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies, today announced the appointment of Richie Cunningham, former Icagen CEO, and Boehringer Ingelheim executive as CEO, effective November 24, 2020, succeeding Steve Hoffman who will remain Board Chairman and CSO, after a successful tenure as CEO since 2015.…

The Healthy Aging Company (THAC) appoints Dr. Lyse Santoro to its Board of Directors as CEO alongside Pr. Christian Brechot remaining as Executive Chairman

– FRANCE, Paris –  T.H.A.C SA (The Healthy Aging Company), a biopharmaceutical company in clinical trials for treating type 2 diabetes in the early phase by fighting insulin resistance, today announced the appointment of Lyse Santoro to its Board of Directors as CEO, succeeding Founder and former CEO Professor Christian Brechot who remains as Executive Chairman of the Board of Directors and CEO, T.H.A.C.…